What ails solid tumor radioimmunotherapy? Journal Article
| Author: | Divgi, C. |
| Article Title: | What ails solid tumor radioimmunotherapy? |
| Keywords: | solid tumor; ibritumomab tiuxetan; rituximab; methodology; neoplasm; neoplasms; cancer immunotherapy; breast cancer; editorial; tumor antigen; monoclonal antibody; immunology; antibodies, monoclonal; antigens, neoplasm; dosimetry; lymphoma; trastuzumab; antigen binding; radiation safety; radioimmunotherapy; tositumomab i 131; cd20 antibody; iodine 131 anti b1 antibody; iodine-131 anti-b1 antibody |
| Journal Title: | Cancer Biotherapy and Radiopharmaceuticals |
| Volume: | 21 |
| Issue: | 2 |
| ISSN: | 1084-9785 |
| Publisher: | Mary Ann Liebert, Inc |
| Date Published: | 2006-05-17 |
| Start Page: | 81 |
| End Page: | 84 |
| Language: | English |
| DOI: | 10.1089/cbr.2006.21.81 |
| PUBMED: | 16706627 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 7" - "Export Date: 4 June 2012" - "CODEN: CBRAF" - "Source: Scopus" |
